Status:
RECRUITING
Comprehensive Intensive Stroke Rehabilitation
Lead Sponsor:
Charles University, Czech Republic
Collaborating Sponsors:
Thomayer University Hospital
Academy of Science Czech Republic
Conditions:
Stroke
Rehabilitation
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
In this study, the investigators aim to assess the effectiveness of the Comprehensive Intensive Rehabilitation Program After Stroke implementing the International Classification of Functioning, Disabi...
Detailed Description
Aim of this study is to define the predictors of effective rehabilitation after stroke. In order to compare the improvement from many different aspects, a wide range of patient characteristic, self-re...
Eligibility Criteria
Inclusion
- adults
- after first ischemic stroke
- early sub-acute phase
- slight to moderately severe disability \[2 - 4 on the Modified Rankin Scale\]
- 0 - 2 on the Pre-Stroke Modified Rankin Score
- potential to accept 4 hours of comprehensive rehabilitation per day and to profit from physiotherapy
- minimal or moderate motor deficit of upper or lower extremities (on NIHSS Item 5 or 6 scores 1-3 points)
- able to perform activities of daily living prior to stroke event (0 - 2 on the Pre-Stroke Modified Rankin Score)
- Czech is participants' native language or its knowledge is at the level of the mother tongue
Exclusion
- low level of consciousness (vegetative state and/or minimally conscious state); severe cognitive decline that would interfere with administration of the tests, premorbid illiteracy, severe visual and/or auditory deficit that would prevent proper completion of the tests
- behavioural disorders and/or lack of cooperation with therapist
- severe medical problems with a poor prognosis, (e.g., severe frailty, advanced and incurable cancer, fracture, cardiovascular disorders as chronic heart failure NYHA III, IV, symptomatic coronary artery disease Angina Severity Class III, IV, respiratory insufficiency as chronic obstructive pulmonary disease GOLD IV, and other severe disease)
Key Trial Info
Start Date :
May 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 15 2026
Estimated Enrollment :
280 Patients enrolled
Trial Details
Trial ID
NCT05323916
Start Date
May 1 2022
End Date
January 15 2026
Last Update
August 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Thomayer University Hospital
Prague, Czechia, 140 59